Ceapro Inc. (OTCMKTS:CRPOF) Corporate Logo

CEAPRO INC ORDINARY SHARES (OTCMKTS:CRPOF) had a decrease of its short interest by 69.44%. FINRA announced short interest of CRPOF’s total 5,500 shares. That’s 69.44% down from 18,000 shares. 1 days will cost CRPOF with 8,700 average volume to restore its previous position.

$0.301 was the last price.Since March 14, 2018 it’s 0.00% down thus . CRPOF underperformed the S&P 500 by 4.37%.

Ceapro Inc., a biotechnology company, engages in developing and commercializing functionally active ingredients for human and animal health markets through the use of proprietary technology and renewable and sustainable resources.The company has $22.87 million market cap. The Company’s products include natural active ingredients, including beta glucan, avenanthramides, oat powder, oat oil, oat peptides, and lupin peptides that are marketed to personal care, cosmetic, medical, and animal health industries through its distribution partners and direct sales; and veterinary therapeutic products, such as an oat shampoo, an ear cleanser, and a dermal complex/conditioner, which are manufactured and marketed for veterinarians in Japan and Asia.Currently it has negative earnings. The company's products and technologies under research and development, or pre-commercial stage consist of a platform using its beta glucan formulations to deliver compounds for treatments in the personal and healthcare sectors; various novel enabling technologies, including Pressurized Gas Expansion drying technology; new oat variety and technologies to enhance the content of avenanthramides; and CeaProve, a diabetes test meal to screen pre-diabetes and to confirm diabetes diagnosis.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.